Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma

Annals of Neurology

Volumn 48, Issue 4, 2000, Pages 603-608

  Reinhardt, Carsten ^a,b,c   Melms, Arthur ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c KH Ingolstadt ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANTIBODY TITER; ARTICLE; CELL MATURATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REMISSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; THYMECTOMY; THYMOMA; THYMUS HYPERPLASIA;

ADULT; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MYASTHENIA GRAVIS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; THYMECTOMY; THYMOMA; THYMUS HYPERPLASIA; THYMUS NEOPLASMS;

EID: 0033797250     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200010)48:4<603::AID-ANA6>3.0.CO;2-1     Document Type: Article

References (34)

1. Myasthenia gravis
2. Etiological factors in development of myasthenia gravis
3. Autoimmune human T lymphocytes specific for acetylchollne receptor
4. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: Heterogeneity of antigenic sites on the α-subunit
5. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor specific T cells
6. + T cells are essential to induce experimental autoimmune myasthenia gravis
7. The thymus in myasthenia gravis
8. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis
9. Immunological factors that influence disease severity in experimental autoimmune myasthenia gravis
10. Thymic subpopulations in myasthenia gravis
11. Changes in lymphocyte subsets in myasthenia gravis
12. Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression
13. Elevated frequencies of natural killer T lymphocytes in myasthenia gravis
14. Mouse CD1-specific NK1 T cells: Development, specificity and function
15. TCR Vα24 and Vβ11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation
16. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
17. Selective reduction of T cells bearing invariant Valpha24 JalphaQ antigen receptor in patients with systemic sclerosis
18. Alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
19. + thymocytes
20. + thymocytes associated with intact thymic structure
21. + thymocytes: A model based on T-cell receptor avidity
22. Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis
23. Skewed TCRVβ repertoire in human thymus persists after thymic emigration: Influence of genomic imposition, thymic maturation and environmental challenge on human TCRVβ usage in vivo
24. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: Selective effect on T-cells in patients with thymic atrophy
25. + T cells are resistant to glucocorticoid-induced apoptosis: Implications for the Th1/Th2 balance
26. - antigen-specific suppressor T cell clones
27. Upregulation of bcl-2 protein in the myasthenic thymus
28. Association of increased numbers of peripheral blood double-negative T lymphocytes with elevated serum IgG levels in severely handicapped children
29. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
30. T-cell dependent B cell activation
31. Interferon γ is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice
32. Suppression of experimental autoimmune myasthenia gravis after CD8 depletion is associated with decreased IFN-gamma and IL-4
33. Regulation of antibody production by helper T cell dones in EAMG is mediated by IL-4 and antigen-specific T cell factors
34. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients